Vironova revolutionizes access to transmission electron microscopy–based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
It has been an amazing experience to participate in Mohammed Homman’s journey developing Vironova, today an innovation leader in the industry of nanoparticle analysis.
– Peter Almberg
Back to top